𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction

✍ Scribed by Antje Mueller; Ulrike Reuner; Basile Landis; Hagen Kitzler; Heinz Reichmann; Thomas Hummel


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
88 KB
Volume
21
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Wilson's disease is a rare autosomal recessive disorder characterized by the accumulation of copper, mainly in the liver and the brain. As copper accumulation in the brain leads to disturbances in basal ganglia function, neurological‐type patients typically present with hypo‐ and hyperkinetic extrapyramidal symptoms, with Parkinsonism being very common. Although there are numerous reports on olfactory deficits in primary neurodegenerative disorders, olfactory function has not been investigated in metabolic disorders presenting with extrapyramidal features. Twenty‐four patients with Wilson's disease participated in the investigation. All patients were treated pharmacologically. They comprised patients with liver disease alone (including mild enzyme elevation in asymptomatic individuals; n = 11) and/or neurological symptoms (n = 13) at the time of testing. Twenty‐one patients underwent both [^18^F]fluoro‐2‐deoxy‐D‐glucose positron emission tomography ([^18^F]FDG‐PET) and magnetic resonance imaging (MRI). The severity of extrapyramidal symptoms was judged using a clinical score system ranging from 0 (no symptoms) to 3 (severe symptoms). In all patients, psychophysical testing was performed using the “Sniffin' Sticks,” which involved tests for odor threshold, discrimination, and identification. Results from the present study revealed that Wilson's disease patients with neurological symptoms show a significant olfactory dysfunction compared to hepatic‐type patients. Individuals who are more severely neurologically affected also present with a more pronounced olfactory deficit. Of interest, there was no significant effect of long‐term treatment with penicillamine on olfactory function. Olfactory function did not correlate significantly with the presence of MRI visible lesions in the basal ganglia or with any regional glucose metabolism as measured by [18]F‐FDG‐PET. In conclusion, these findings indicate that the underlying pathological alterations with degeneration in the basal ganglia and neuronal loss in association with a marked increase of the copper content in this brain region play a role in the olfactory deficit. © 2006 Movement Disorder Society


📜 SIMILAR VOLUMES


Olfactory dysfunction is associated with
✍ James F. Morley; Daniel Weintraub; Eugenia Mamikonyan; Paul J. Moberg; Andrew D. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract Hyposmia, psychiatric disorders, and cognitive problems are common nonmotor manifestations in Parkinson's disease, but how they are related remains unclear. We investigated the relationship between olfactory dysfunction and neuropsychiatric manifestations and performed a cross‐sectional

Nonmotor symptoms are independently asso
✍ Huijuan Li; Meifen Zhang; Ling Chen; June Zhang; Zhong Pei; Ailing Hu; Qing Wang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

## Abstract We performed a cross‐sectional study of 82 Chinese patients with Parkinson's disease (PD) enrolled during an 18‐month period using a clinical interview to assess the prevalence of nonmotor symptoms (NMS), the association with disease severity and motor status, and the impact on patients

Glucocerebrosidase gene mutations are as
✍ Anton Emelyanov; Tatyana Boukina; Andrey Yakimovskii; Tatyana Usenko; Alesya Dro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB 👁 1 views

FIG. 1. MRI showed symmetric (A) hypointensity signal on T1weighted imaging and (B) hyperintensity signal on T2-weighted imaging in bilateral substantia nigra on admission. A repeated MRI after 3 months showed resolution of the lesions on (C) T2-weighted imaging and (D) T1-weighted imaging.